ADAMTS13 在各类疾病中的作用
摘要
关键词
全文:
PDF参考
[1]Fujikawa K，Suzuki H，McMullen B，et al. Purification of human von Willebrand factor-cleaving protease and its identification as
a new member of the metalloproteinase family[J]. Blood，2001，98(6）：1662-1666.
[2]Zheng X，Chung D，Takayama T K，et al. Structure of von Willebrand factor-cleaving protease(ADAMTS13），a metalloprotease
involved in thrombotic thrombocytopenic purpura[J]. J Biol Chem，2001，276(44）：41059-41063.
[3]Gerritsen H E，Robles R，Lämmle B，et al. Partial amino acid sequence of purified von Willebrand factor-cleaving protease[J]. Blood，
2001，98(6）：1654-1661.
[4]Atiq F，O'Donnell J S. Novel functions for von Willebrand factor[J]. Blood，2024，144(12）：1247-1256.
[5]Lenting P J，Christophe O D，Denis C V. von Willebrand factor biosynthesis，secretion，and clearance：connecting the far ends[J].
Blood，2015，125(13）：2019-2028.
[6]Hrdinová J，D'Angelo S，Graça N，et al. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura：interplay
between genes and environmental triggers[J]. Haematologica，2018，103(7）：1099-1109.
[7]Kremer H J，Coppo P，Lämmle B，et al. Thrombotic thrombocytopenic purpura[J]. Nat Rev Dis Primers，2017，3：17020[8]Bonnez Q ， Sakai K ， Vanhoorelbeke K. ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic
Thrombocytopenic Purpura[J]. J Clin Med，2023，12(19）.
[9]Levy G G，Nichols W C，Lian E C，et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic
purpura[J]. Nature，2001，413(6855）：488-494.
[10]Scully M，Yarranton H，Liesner R，et al. Regional UK TTP registry：correlation with laboratory ADAMTS 13 analysis and clinical
features[J]. Br J Haematol，2008，142(5）：819-826.
[11]Coppo P，Schwarzinger M，Buffet M，et al. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic
microangiopathies：the French TMA reference center experience[J]. PLoS One，2010，5(4）：e10208.
[12]Rock G A，Shumak K H，Buskard N A，et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic
thrombocytopenic purpura. Canadian Apheresis Study Group[J]. N Engl J Med，1991，325(6）：393-397.
[13]Zheng X L，Vesely S K，Cataland S R，et al. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura[J]. J Thromb
Haemost，2020，18(10）：2496-2502.
[14]Scully M，Cataland S R，Peyvandi F，et al. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura[J]. N Engl
J Med，2019，380(4）：335-346.
[15]Kremer H J，George J N. Hereditary Thrombotic Thrombocytopenic Purpura[J]. N Engl J Med，2019，381(17）：1653-1662.
通讯作者：金圣宇，男，1976.11.11，延边大学附属医院，血液内科主任，医学博士，出凝血方向。
(1 摘要 Views, 1 PDF Downloads)
Refbacks
- 当前没有refback。